Imaging dopamine D4 receptors in the living primate brain: A positron emission tomography study using the novel D1/ D4 antagonist [11C]SDZ GLC 756

The dopamine D4 receptor has lately attracted interest since it has been hypothesized to be involved in the pathogenesis and pharmacotherapy of neuropsychiatric diseases. The present study provides first in vivo evidence of dopamine D4 receptors in primate brain using a [11C]benzo[g]quinoline, the novel radioligand [11C]SDZ GLC 756 ([11C]GLC: in vitro dissociation constants at human receptor clones [nM]: 1.10 at D1; 0.40 at D2; 25 at D3; 0.18 at D4.2; 6.03 at D5). Dynamic positron emission tomography scans were performed on healthy baboons (Papio hamadryas, n = 3). Specific receptor binding (SB) was calculated for striatum and neocortex (frontal, temporal, parietal, and occipital) based on the differences between the regional and the cerebellar concentration of [11C]. Blockade of D1 and D5 receptors by SCH23390 (1.7 μmol/ kg) diminished SB in the striatum by 55 ± 4% (mean ± standard deviation, P < 0.05) and in the frontal cortex by 13 ± 8% (P < 0.05) when compared to SB in the unblocked state (SBD1–D5). In the presence of the dopamine antagonists SCH23390 (1.7 μmol/ kg) and raclopride (5.7 μmol/ kg)—which mask the D1, D2, D3, and D5 subtypes—SB of [11C]GLC to D4 receptors (SBD4) was demonstrated in the striatum and all cortical regions of interest. In the striatum, the ratio of SBD4/ SBD1–D5 was 0.13 ± 0.07. In the neocortex, SBD4/ SBD1–D5 was notably higher (0.77 ±0.29; mean of all cortical regions of interest). The widespread distribution of dopamine D4 receptors suggests a basic functional role of this receptor subtype in the modulation of cortical and subcortical neuronal activity. Synapse 30:341–350, 1998. © 1998 Wiley‐Liss, Inc.

[1]  A. Getson,et al.  The effects of a selective D4 dopamine receptor antagonist (L-745,870) in acutely psychotic inpatients with schizophrenia. D4 Dopamine Antagonist Group. , 1997, Archives of general psychiatry.

[2]  S. Stone-Elander,et al.  Preparation of 11C-labelled SCH 23390 for the in vivo study of dopamine D-1 receptors using positron emission tomography. , 1986, International journal of radiation applications and instrumentation. Part A, Applied radiation and isotopes.

[3]  P. Seeman,et al.  Dopamine D4 receptors elevated in schizophrenia , 1993, Nature.

[4]  P. Seeman,et al.  Multiple dopamine D4 receptor variants in the human population , 1992, Nature.

[5]  P. Goldman-Rakic,et al.  Localization of dopamine D4 receptors in GABAergic neurons of the primate brain , 1996, Nature.

[6]  A. Ford,et al.  α1-Adrenoceptor classification: sharpening Occam's razor , 1994 .

[7]  S. Cichon,et al.  Human dopamine D4 receptor gene: frequent occurrence of a null allele and observation of homozygosity. , 1994, Human molecular genetics.

[8]  M. Caron,et al.  Recent advances in the molecular biology of dopamine receptors. , 1993, Annual review of neuroscience.

[9]  T Greitz,et al.  Substituted benzamides as ligands for visualization of dopamine receptor binding in the human brain by positron emission tomography. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[10]  E G Jones,et al.  Decrease in sigma but no increase in striatal dopamine D4 sites in schizophrenic brains. , 1996, European journal of pharmacology.

[11]  M. Reivich,et al.  Pet imaging studies of dopamine D2 receptors: Comparison of [18F]N‐Methylspiperone; and the benzamide analogues [18F]MABN and [18F]MBP in baboon brain , 1995, Synapse.

[12]  Steven G. Potkin,et al.  Decrease in σ but no increase in striatal dopamine D4 sites in schizophrenic brains , 1996 .

[13]  P. Goldman-Rakic,et al.  Distribution of dopaminergic receptors in the primate cerebral cortex: Quantitative autoradiographic analysis using [3H]raclopride, [3H]spiperone and [3H]SCH23390 , 1991, Neuroscience.

[14]  J. Petter Gustavsson,et al.  D2 dopamine receptors and personality traits , 1997, Nature.

[15]  B. Berger,et al.  Dopaminergic innervation of the cerebral cortex: unexpected differences between rodents and primates , 1991, Trends in Neurosciences.

[16]  E. Rota Kops,et al.  Performance characteristics of an eight-ring whole body PET scanner. , 1990, Journal of computer assisted tomography.

[17]  Christer Halldin,et al.  Distribution of D1- and D2-Dopamine Receptors, and Dopamine and Its Metabolites in the Human Brain , 1994, Neuropsychopharmacology.

[18]  E. Nestler.  Hard target: Understanding dopaminergic neurotransmission , 1994, Cell.

[19]  G. Reynolds,et al.  Absence of detectable striatal dopamine D4 receptors in drug-treated schizophrenia. , 1995, European journal of pharmacology.

[20]  F. Bloom,et al.  Psychopharmacology: The Fourth Generation of Progress , 1995 .

[21]  M. Holschbach,et al.  An on-line method for the preparation of n.c.a. [11CH3]trifluoromethanesulfonic acid methyl ester , 1993 .

[22]  J. Thorner,et al.  Model systems for the study of seven-transmembrane-segment receptors. , 1991, Annual review of biochemistry.

[23]  D. Riche,et al.  Anatomical atlas of the baboon's brain in the orbito-meatal plane used in experimental positron emission tomography , 1988, Brain Research Bulletin.

[24]  D. Grandy,et al.  Molecular diversity of the dopamine receptors. , 1993, Annual review of pharmacology and toxicology.

[25]  P. Seeman,et al.  Long-term haloperidol elevates dopamine D4 receptors by 2-fold in rats. , 1995, European journal of pharmacology.

[26]  D. M. Jackson,et al.  Dopamine receptors: molecular biology, biochemistry and behavioural aspects. , 1994, Pharmacology & therapeutics.

[27]  J. Nobrega,et al.  Dopamine D2‐like sites in schizophrenia, but not in Alzheimer's, Huntington's, or control brains, for [3H]benzquinoline , 1997, Synapse.

[28]  A. Ford,et al.  Alpha 1-adrenoceptor classification: sharpening Occam's razor. , 1994, TIPS - Trends in Pharmacological Sciences.

[29]  N. Osborne.  Handbook of chemical neuroanatomy, Vol. 2: Classical Transmitters in the CNS Part 1. Edited by A. Björklund and T. Hökfelt. ISBN 0444 90330 5. Price: $104. Elsevier, 1984 , 1986, Neurochemistry International.

[30]  T. Hyde,et al.  Distribution of putative D4 dopamine receptors in postmortem striatum from patients with schizophrenia , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[31]  P. Goldman-Rakic,et al.  Modulation of memory fields by dopamine Dl receptors in prefrontal cortex , 1995, Nature.

[32]  E. Nestler.  An emerging pathophysiology , 1997, Nature.

[33]  T. Hökfelt,et al.  Classical transmitters in the CNS , 1984 .

[34]  B. Långström,et al.  Receptor binding and selectivity of three 11C‐labelled dopamine receptor antagonists in the brain of Rhesus monkeys studied with positron emission tomography , 1988, Acta neurologica Scandinavica.

[35]  P. Seeman,et al.  Atypical Neuroleptics Have Low Affinity for Dopamine D2 Receptors or Are Selective for D4 Receptors , 1997, Neuropsychopharmacology.

[36]  R. Conley,et al.  D2-type dopamine receptors in postmortem human brain sections from normal and schizophrenic subjects. , 1996, Neuroreport.

[37]  M. Holschbach,et al.  A new and simple on-line method for the preparation of n.c.a. [11C]methyl iodide , 1993 .

[38]  A. Awad,et al.  Psychopharmacology: The Fourth Generation of Progress , 1998, CNS Spectrums.

[39]  O. Civelli,et al.  Epinephrine and Norepinephrine Act as Potent Agonists at the Recombinant Human Dopamine D4 Receptor , 1997, Journal of neurochemistry.

[40]  P. Seeman,et al.  Schizophrenia: elevation of dopamine D4-like sites, using [3H]nemonapride and [125I]epidepride. , 1995, European journal of pharmacology.

[41]  S. J. Gatley,et al.  Decreased striatal dopaminergic responsiveness in detoxified cocaine-dependent subjects , 1997, Nature.